| Bioactivity | PLK1/p38γ-IN-1(compound 14) is a multitarget inhibitors ofPLK1andp38γ. PLK1/p38γ-IN-1inhibits the growth of human hepatocellular carcinoma and hepatoblastoma cells in vitro[1]. |
| Name | PLK1/p38γ-IN-1 |
| CAS | 2418614-81-8 |
| Formula | C21H26ClN3O2 |
| Molar Mass | 387.90 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Cheng Z, et al. Chee Wezen X. Combination of QSAR Modeling and Hybrid-Based Consensus Scoring to Identify Dual-Targeting Inhibitors of PLK1 and p38γ. J Chem Inf Model. 2023;63(21):6912-6924. |
PLK1/p38γ-IN-1
CAS: 2418614-81-8 F: C21H26ClN3O2 W: 387.90
PLK1/p38γ-IN-1(compound 14) is a multitarget inhibitors ofPLK1andp38γ. PLK1/p38γ-IN-1inhibits the growth of human hep
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.